Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Jurnal Multidisiplin Sahombu
Elis Citra Lestari
Unknown Affiliation
Arts Civil Engineering, Building, Construction & Architecture Economics, Econometrics & Finance Environmental Science Law, Crime, Criminology & Criminal Justice

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
The Influence Of Financial Distress, Return On Assets (ROA) And Company Size On Profit Management (Study On Pharmaceutical Companies Listed On The Indonesian Stock Exchange (BEI) In 2016-2022) Nastiti Rizky Shiyammurti; Elis Citra Lestari
Jurnal Multidisiplin Sahombu Vol. 4 No. 01 (2024): Jurnal Multidisiplin Sahombu, 2024
Publisher : Sean Institute

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The aim of this research is to examine and analyze the influence of financial distress, Return on assets (ROA) and company size on earnings management in Food and Beverage Companies listed on the Indonesia Stock Exchange in 2016 -2022 . Financial distress uses model Altman Z - score , return on assets and company size ( size ) which are measured using natural logarithms. The total sample used in this research was 8 companies through purposive sampling. The data used in this research is secondary data. To test the hypothesis in this research, the multiple linear regression analysis method was used with a significance level of 0.05 using eviews 12 . The coefficient of determination in this research is 5 7 % which can be explained by the independent variables, namely financial distress, return on assets (ROA) and company size on earnings management variables . The results of this research indicate that financial distress influences earnings management , return in assets (ROA) influences earnings management , but company size has no influence on earnings management . Financial distress, return on assets and company size influence simultaneously or together on earnings management in pharmaceutical companies listed on the Indonesia Stock Exchange (BEI). Because the significance level is <0.05.
Co-Authors Nastiti Rizky Shiyammurti